---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-26-000003"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:49:43.275712+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics posts record FY2025 revenue $236.1M (+15% YoY); guides FY2026 revenue $262-266M

## Summary
- Q4 2025 revenue $61.3M (+16% YoY); domestic $48.4M (+13%), international $12.9M (+32%).
- FY2025 free cash flow usage over 50% lower than FY2024; Q4 FCF $6-7M.
- FY2026 revenue guidance $262-266M (11–13% growth); expects ~$25M Adjusted EBITDA.
- Received EUMDR certification for Response Spine and trauma/deformity implants.
- Helped 37,500 children in Q4; nearly 1.3 million since inception.

## SEC filing metadata
- accession: 0001425450-26-000003
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000003/0001425450-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000003/kids-20260112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-26-000003
- JSON: https://secwatch.observer/filing/0001425450-26-000003.json
- Plain text: https://secwatch.observer/filing/0001425450-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.